Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Seesha Takagishi"'
Autor:
Paul Nghiem, Jaehyuk Choi, Timothy A. Chan, Seesha Takagishi, Tessa Marx, Ryan Doumani, Amy Bestick, Daniel Hippe, Kelly G. Paulson, Nadeem Riaz, Vladimir Makarov, Christopher W. Lewis, Natalie Vandeven
Supplementary Figure 1. MCC-UP status predicts better overall but not recurrence-free survival among patients with stage IV disease. Panel A depicts overall survival and panel B depicts recurrence-free survival among 20 stage IV MCC patients. Overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3cf41b589abdcae0272b2b00c0fb16
https://doi.org/10.1158/1078-0432.22465563
https://doi.org/10.1158/1078-0432.22465563
Autor:
Paul Nghiem, Jaehyuk Choi, Timothy A. Chan, Seesha Takagishi, Tessa Marx, Ryan Doumani, Amy Bestick, Daniel Hippe, Kelly G. Paulson, Nadeem Riaz, Vladimir Makarov, Christopher W. Lewis, Natalie Vandeven
Supplemental Figure 2. MCC-UP status predicts better survival among non-immunosuppressed patients with either stage IIIB or IV disease. Panel A depicts MCC-specific survival B illustrates overall survival and C indicated recurrence-free survival for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1343c46b01983b4705bb1ded637513d3
https://doi.org/10.1158/1078-0432.22465560
https://doi.org/10.1158/1078-0432.22465560
Autor:
Paul Nghiem, Jaehyuk Choi, Timothy A. Chan, Seesha Takagishi, Tessa Marx, Ryan Doumani, Amy Bestick, Daniel Hippe, Kelly G. Paulson, Nadeem Riaz, Vladimir Makarov, Christopher W. Lewis, Natalie Vandeven
Patients with unknown primary lesions and without immunosuppression have improved survival among patients with stage IIIB and stage IV MCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ba8637ed5702a21d15df59e4b7dd7d
https://doi.org/10.1158/1078-0432.22465557.v1
https://doi.org/10.1158/1078-0432.22465557.v1